The company relies on third-party suppliers and outsourcing for manufacturing, which exposes it to risks such as supply disruptions, quality issues, non-compliance, and price fluctuations. Manufacturing challenges or disruptions at the company's facilities may negatively impact operations and increase costs. Compliance with regulatory requirements, including addressing FDA warning letters, is essential to prevent product restrictions or market withdrawal.
Dexcom Inc's Comment on Supply Chain
The company relies on third-party suppliers and outsourcing for manufacturing, which exposes it to risks such as supply disruptions, quality issues, non-compliance, and price fluctuations. Manufacturing challenges or disruptions at the company's facilities may negatively impact operations and increase costs. Compliance with regulatory requirements, including addressing FDA warning letters, is essential to prevent product restrictions or market withdrawal.
Sources:
Dexcom Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Dexcom Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
